Alignment Healthcare (ALHC) reported first-quarter 2026 revenue of $1.24 billion, up 33.26% year‑over‑year, driven by higher membership and service volumes. Gross profit rose to $144.5 million, a 36.26% increase versus the year‑ago quarter.
The company narrowly missed revenue expectations, with the consensus at $1.24 billion versus actual revenue of $1.24 billion, a shortfall of $6.72 million. Reported diluted EPS of $0.05 exceeded the estimate of about $0.01.
Following the release, the stock moved after hours showing a change of -7.72% since market close.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Alignment Healthcare Inc. Insider Trading Activity
Alignment Healthcare Inc. insiders have traded $ALHC stock on the open market 57 times in the past 6 months. Of those trades, 0 have been purchases and 57 have been sales.
Here’s a breakdown of recent trading of $ALHC stock by insiders over the last 6 months:
- ATLANTIC, L.P. GENERAL sold 11,119,494 shares for an estimated $206,489,003
- ATLANTIC (ALN HLTH), L.P. GENERAL sold 11,119,494 shares for an estimated $206,489,003
- JOHN E KAO (Chief Executive Officer) has made 0 purchases and 17 sales selling 2,293,593 shares for an estimated $44,105,144.
- DAWN CHRISTINE MARONEY (President) has made 0 purchases and 14 sales selling 926,084 shares for an estimated $18,366,502.
- CHRISTOPHER J JOYCE (Chief Legal and Admin. Officer) has made 0 purchases and 6 sales selling 89,642 shares for an estimated $1,665,606.
- ROBERT L. SCAVO (Chief Information Officer) has made 0 purchases and 5 sales selling 84,870 shares for an estimated $1,575,263.
- ANDREAS P. WAGNER (Chief Human Resources Officer) has made 0 purchases and 4 sales selling 66,958 shares for an estimated $1,273,939.
- HYONG KIM (Chief Medical Officer) has made 0 purchases and 4 sales selling 47,604 shares for an estimated $918,603.
- JOSEPH S KONOWIECKI has made 0 purchases and 2 sales selling 29,832 shares for an estimated $554,679.
- SEBASTIAN BURZACCHI (COO - Mgmt Services Org) has made 0 purchases and 2 sales selling 27,946 shares for an estimated $516,427.
- JAMES M HEAD (Chief Financial Officer) sold 11,100 shares for an estimated $233,987
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
Alignment Healthcare Inc. Hedge Fund Activity
We have seen 163 institutional investors add shares of Alignment Healthcare Inc. stock to their portfolio, and 104 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GENERAL ATLANTIC, L.P. removed 11,119,494 shares (-45.8%) from their portfolio in Q4 2025, for an estimated $219,610,006
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 10,874,567 shares (-86.5%) from their portfolio in Q4 2025, for an estimated $214,772,698
- FMR LLC added 6,574,721 shares (+81.4%) to their portfolio in Q4 2025, for an estimated $129,850,739
- WELLINGTON MANAGEMENT GROUP LLP added 2,981,166 shares (+26.9%) to their portfolio in Q4 2025, for an estimated $58,878,028
- MILLENNIUM MANAGEMENT LLC removed 2,924,624 shares (-53.3%) from their portfolio in Q4 2025, for an estimated $57,761,324
- CAPITAL WORLD INVESTORS added 2,238,147 shares (+inf%) to their portfolio in Q4 2025, for an estimated $44,203,403
- LOOMIS SAYLES & CO L P added 2,236,058 shares (+inf%) to their portfolio in Q4 2025, for an estimated $44,162,145
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
Alignment Healthcare Inc. Analyst Ratings
Wall Street analysts have issued reports on $ALHC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 01/06/2026
- JP Morgan issued a "Overweight" rating on 11/24/2025
To track analyst ratings and price targets for Alignment Healthcare Inc., check out Quiver Quantitative's $ALHC forecast page.
Alignment Healthcare Inc. Price Targets
Multiple analysts have issued price targets for $ALHC recently. We have seen 6 analysts offer price targets for $ALHC in the last 6 months, with a median target of $24.0.
Here are some recent targets:
- John Stansel from JP Morgan set a target price of $26.0 on 02/05/2026
- Ryan Langston from TD Cowen set a target price of $25.0 on 01/16/2026
- Kevin Caliendo from UBS set a target price of $21.0 on 01/14/2026
- Jessica Tassan from Piper Sandler set a target price of $30.0 on 01/06/2026
- Andrew Mok from Barclays set a target price of $18.0 on 11/03/2025
